Lauras lab.indd
Mumbai, March 04, 2018: Laurus Labs Ltd said that the USFDA audit has been successfully completed without observations – ZERO 483 for its Unit 2 (formulations unit). The inspection was carried out from Feb 26 2018 to March 1, 2018.
Laurus Labs Ltd has also received its maiden Approval from United States Food and Drug Administration (U. S FDA) for Tenofovir Disoproxil Fumarate Tablets 300mg.
Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science Ltd.
Corporate Comm India(CCI Newswire)
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…